vs
Side-by-side financial comparison of AC Immune SA (ACIU) and GSK plc (GSK). Click either name above to swap in a different company.
AC Immune SA is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics and diagnostic solutions for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and rare tauopathies. It operates globally, partners with leading pharmaceutical enterprises, and prioritizes addressing unmet medical needs in neurological care segments.
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $1.4M | — | ||
| Q2 24 | $755.7K | — | ||
| Q3 22 | $4.3M | — |
| Q2 25 | $-23.3M | — | ||
| Q2 24 | $-25.0M | — | ||
| Q3 22 | $-14.9M | — |
| Q2 25 | -1484.5% | — | ||
| Q2 24 | -3051.1% | — | ||
| Q3 22 | -342.2% | — |
| Q2 25 | -1622.4% | — | ||
| Q2 24 | -3313.0% | — | ||
| Q3 22 | -343.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
